Clinical Trial Update: An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 efficacy trial of an inactivated Enterovirus Type 71 vaccine for Hand, Foot and Mouth Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• EV71 vaccine (inactivated) (Enterovirus Type 71 vaccine)

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot and Mouth Disease | Phase 3 | Status: COMPLETED